Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production

References

• Einollahi B, Einollahi H, Rostami Z. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia. Exp Clin Transplant 2011; 9:376–380.
   PubMed Web of Science ®Google Scholar
• Dincer HE, Dincer AP, Levinson DJ. Asymptomatic hyperuricaemia: to treat or not to treat. Cleve Clin J Med 2002; 69:594–608.
   PubMed Web of Science ®Google Scholar
• Hayden MR, Tyagi SC. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metabol 2004; 1:10.
   Google Scholar
• Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology 2009; 114:300–305.
   Google Scholar
• Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, Daunhauer A, . Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89:12–17.
   PubMed Web of Science ®Google Scholar
• Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, Gerlach E. Role of uric acid as endogenous radical scavenger and antioxidant. Chest 1991; 100:176S–181S.
   PubMed Web of Science ®Google Scholar
• Landmesser U, Merten R, Spiekermann S, B ttner K, Drexler H, Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000; 101:2264–2270.
   PubMed Web of Science ®Google Scholar
• Kannelis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005; 25:39–42.
   Google Scholar
• Xu D, Feng L. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure. Med Hypotheses 2008; 70:578–581.
   Google Scholar
• Papežíková I, Pekarová M, Lojek A, Kubala L. The effect of uric acid on homocysteine-induced endothelial dysfunction in bovine aortic endothelial cells. Neuroendocr Lett 2009; 30: 153–156.
   Google Scholar
• Vistejnova L, Dvorakova J, Hasova M, Muthny T, Velebny V, Soucek K, Kubala L. The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques. Neuroendocr Let 2009; 30:121–127.
   PubMed Web of Science ®Google Scholar
• Prochazkova J, Kubala L, Kotasova H, Gudernova I, Sramkova Z, Pekarova M, . ABC transporters affect the detection of intracellular oxidants by fluorescent probes. Free Rad Res 2011; 45:779–787.
   PubMed Web of Science ®Google Scholar
• Kubala L, Schmelzer KR, Klinke A, Kolarova H, Baldus S, Hammock BD, Eiserich JP. Modulation of arachidonic and linoneic acid metabolites in myeloperoxidase-deficient mice during acute inflammation. Free Rad Bio Med 2010; 48:1311–1320.
   Google Scholar
• Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, Patel J. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol 2008; 295: C1183–C1190.
   PubMed Web of Science ®Google Scholar
• Schiffrin E. Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation. Hypertension 2008; 51:31–32.
   PubMed Web of Science ®Google Scholar
• Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 2001; 280: F193–F206.
   PubMed Web of Science ®Google Scholar
• Kang DH, Kwang Park SK, Lee IK, Johnson RJ. Uric acid–induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16:3553–3562.
   PubMed Web of Science ®Google Scholar
• Verma S. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106:913–919.
   PubMed Web of Science ®Google Scholar
• Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35:746–751.
   PubMed Web of Science ®Google Scholar
• Farquharson CAJ, Butler R, Hill A, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002; 106:221–226.
   PubMed Web of Science ®Google Scholar
• Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, . Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002; 105:2619–2624.
   PubMed Web of Science ®Google Scholar
• Guthikonda S, Sinkey C, Barenz T, Haynes WG. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 2003; 107:416–421.
   PubMed Web of Science ®Google Scholar
• George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag 2009; 5:265–272
   PubMedGoogle Scholar
• Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin Sci 2005; 109:217–226.
   PubMed Web of Science ®Google Scholar
• Baldus S, Kőster R, Chumley P, Heitzer T, Rudolph V, Ostad MA, . Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 2005; 39:1184–1190.
   PubMed Web of Science ®Google Scholar
• Zharikov S, Krotova K, Johnson R, Baylis C, Block ER. Uric acid reduces nitric oxide (NO) bioavailability in endothelial cells by activating the L-arginine/arginase pathway. FASEB J 2007; 21:745.
   Google Scholar
• Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002; 19:640–653.
   PubMed Web of Science ®Google Scholar